Easy Six® · Panacea Biotec · 0.5 mL Single Dose · Intramuscular Use · Shake Well Before Use
Full composition per 0.5 mL · Aluminium phosphate adjuvant · Store 2–8°C · Not to be Frozen · Shake Well
Bacterial throat membrane infection that can block airways and cause heart failure. Potentially fatal in unvaccinated children.
Lockjaw – caused by a bacterial toxin leading to severe muscle spasms. No cure exists; prevention is only through vaccination.
Highly contagious respiratory infection causing severe coughing fits, especially dangerous in infants under 6 months.
Viral liver infection that can become chronic, leading to cirrhosis or liver cancer later in life if acquired in infancy.
Viral infection that can cause irreversible paralysis. IPV component provides inactivated, safe protection.
Haemophilus influenzae type b can cause meningitis, pneumonia and epiglottitis in young children.
Primary target: all healthy infants starting from 6 weeks of age. 6-in-1 vaccines are part of the extended private-market immunisation schedule recommended by IAP.
Preterm infants are highly vulnerable to Hib meningitis, pertussis and hepatitis B. Easy Six is given at chronological age (6 weeks), not corrected gestational age.
Babies with congenital heart disease, chronic lung disease or other conditions benefit from reduced injection burden through combination vaccination.
Infants who will attend daycare or have older siblings at school are at higher exposure risk for pertussis and should complete the primary series on time.
Families wanting comprehensive 6-in-1 protection at a lower cost than acellular (DTaP) imported options often choose Easy Six.
As per Panacea Biotec manufacturer label. Each 0.5 mL dose typically contains:
| Component | Quantity | Notes |
|---|---|---|
| ACTIVE INGREDIENTS – 6 ANTIGENS | ||
| Diphtheria Toxoid | ≥ 30 IU | Adsorbed on Aluminium Phosphate |
| Tetanus Toxoid | ≥ 40 IU | Adsorbed on Aluminium Phosphate |
| B. pertussis (Whole Cell) | ≥ 4 IU | Whole-cell killed Bordetella pertussis – strong immunogenicity |
| HBsAg (rDNA) | ≈ 10 mcg | Recombinant Hepatitis B surface antigen |
| Inactivated Poliovirus (IPV) | Types 1, 2, 3 | Salk-strain inactivated polio antigens |
| Hib-PRP (conjugated) | ≈ 10 mcg | Polyribosylribitol phosphate conjugated to tetanus toxoid |
| EXCIPIENTS & ADJUVANT | ||
| Aluminium Phosphate | ≤ 1.25 mg | Adjuvant – enhances immune response |
| Thiomersal / Preservative | Trace | As per manufacturer formulation |
| Water for Injection | q.s. to 0.5 mL | Diluent |
Exact excipient composition may vary slightly by batch – always refer to the manufacturer package insert supplied with each dose.
| Dose | Age | Vaccine | Notes |
|---|---|---|---|
| HEPATITIS B – BIRTH DOSE (Given Separately) | |||
| HepB Birth | At birth (within 24 hrs) | HepB monovalent (separate) | Birth dose MUST be given before starting the 6-in-1 series |
| EASY SIX PRIMARY SERIES (3 DOSES) | |||
| Dose 1 | 6 Weeks | Easy Six (0.5 mL IM) | Anterolateral thigh · First 6-in-1 dose |
| Dose 2 | 10 Weeks | Easy Six (0.5 mL IM) | Minimum 4-week gap from Dose 1 |
| Dose 3 | 14 Weeks | Easy Six (0.5 mL IM) | Completes primary series |
| BOOSTER | |||
| Booster | 16–18 Months | Easy Six or DTwP-containing booster | As advised by paediatrician; may use separate boosters thereafter |
Schedule shown follows IAP private-market recommendations. Exact timing may be adjusted by your paediatrician based on the infant's health and catch-up needs.
The 0.5 mL dose delivers six inactivated/toxoid antigens (D, T, wP, HepB, IPV, Hib) simultaneously via intramuscular injection.
The immune system recognises each antigen and begins producing antibodies specific to diphtheria and tetanus toxins, pertussis bacteria, HBsAg, poliovirus and Hib capsular polysaccharide.
Repeated doses at 6, 10 and 14 weeks build increasingly strong immune memory, so the body can respond rapidly on future exposure to any of the six pathogens.
The booster dose at 16–18 months reinforces long-term protection through early childhood, when exposure risk from daycare and school is highest.
Easy Six uses whole-cell pertussis (DTwP) – which causes more local and systemic reactions than acellular pertussis (DTaP). These reactions are expected and reflect the vaccine's strong immune activation.
VacciHub nurses observe every infant for 15–20 minutes post-vaccination and carry emergency response kits during home visits.
| Feature | Easy Six (Panacea Biotec) | Hexasiil PFS (Serum Institute) | Infanrix Hexa (GSK) |
|---|---|---|---|
| Manufacturer | ✓ Panacea Biotec (India) | Serum Institute (India) | GSK (Belgium, imported) |
| Pertussis type | Whole cell (DTwP) | Whole cell (DTwP) | ✓ Acellular (DTaP) – fewer reactions |
| Diseases covered | 6 (D, T, wP, HepB, IPV, Hib) | 6 (D, T, wP, HepB, IPV, Hib) | 6 (D, T, aP, HepB, IPV, Hib) |
| Fever risk post-dose | Higher (DTwP – common) | Higher (DTwP – common) | ✓ Lower (acellular – less reactogenic) |
| Typical price positioning | ✓ Most affordable option | Comparable / mid-range | Premium (imported) |
| Availability in India | ✓ Widely available | ✓ Widely available | Available at select clinics |
All three are effective, WHO-aligned 6-in-1 vaccines. The main practical difference is the pertussis component (whole-cell vs acellular) and price – discuss with your paediatrician which best fits your child's needs and budget.
Trained, certified nurses administer Easy Six safely at your doorstep – no clinic waiting rooms or travel needed.
Every dose is transported and stored at 2–8°C using validated cold-chain equipment, right up to injection.
No hidden charges – the price you see includes the vaccine, nurse visit and post-vaccination monitoring.
Receive a digital vaccination certificate and reminders for upcoming doses so you never miss a schedule date.
Our team is available on call to answer questions before and after vaccination.
Easy Six is manufactured by Panacea Biotec Ltd., an Indian vaccine manufacturer, as a 6-in-1 combination vaccine protecting against Diphtheria, Tetanus, Pertussis, Hepatitis B, Polio and Hib.
Easy Six is priced at Rs.2,995 per dose at VacciHub, inclusive of certified nurse home vaccination in Delhi NCR.
The primary series is given at 6, 10 and 14 weeks of age, with a booster typically at 16–18 months, alongside a separate Hepatitis B birth dose.
Easy Six contains whole-cell pertussis (DTwP), which triggers a strong immune response but causes somewhat more fever and injection-site reactions than acellular (DTaP) vaccines.
Common side effects include injection-site pain and swelling, fever, fussiness and drowsiness. Rare reactions include high fever, prolonged inconsolable crying and febrile seizures – all monitored by VacciHub nurses.
Both are DTwP-based 6-in-1 combination vaccines. Easy Six is manufactured by Panacea Biotec while Hexasiil PFS is made by Serum Institute of India; both offer comparable protection at similar price points.
Yes, Easy Six can be co-administered with other scheduled vaccines like Rotavirus and Pneumococcal vaccines at the same visit, using separate injection sites.
Yes, VacciHub offers certified-nurse home vaccination for Easy Six across Delhi, Gurgaon, Noida, Ghaziabad and Faridabad with proper cold-chain maintenance.
Copyright © All Rights Reserved VacciHub by PSTRIDE SOLUTIONS LLP